Cambient Family Office’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Sell
3,642
-898
-20% -$78.7K 0.04% 200
2026
Q1
$412K Buy
4,540
+335
+8% +$30.7K 0.06% 157
2025
Q4
$379K Buy
+4,205
New +$399K 0.05% 154

Other funds holding ZBH

Cambient Family Office's ZBH Position: Q2 2026 in Review

Cambient Family Office reduced its Zimmer Biomet (ZBH) stake by 20% in Q2 2026, selling an estimated $78.7K and leaving 3,642 shares worth $314K. The position accounts for 0.04% of the portfolio, ranked #200.

Cambient Family Office first reported a position in ZBH in Q4 2025 and has held it in 3 quarters since. The position peaked at $412K in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Cambient Family Office held 3,642 shares of Zimmer Biomet worth $314K as of Q2 2026.
  • Cambient Family Office sold 898 Zimmer Biomet shares in Q2 2026, an estimated $78.7K.
  • Zimmer Biomet made up 0.04% of Cambient Family Office's portfolio in Q2 2026, its #200 holding.
  • Cambient Family Office first reported a position in Zimmer Biomet in Q4 2025 and has held it in 3 quarters since.
  • Cambient Family Office's Zimmer Biomet position peaked at $412K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.